Stay updated on EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Sign up to get notified when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for the EPIK-B2 study is displayed, describing alpelisib with trastuzumab and pertuzumab for advanced HER2-positive breast cancer. It includes study design, participation criteria, locations, outcome measures, and information about sharing participant-level data.
    Difference
    61%
    Check dated 2026-11-09T13:51:56.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer’s site revision indicator changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T13:46:45.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    An NIH-wide banner announces transition updates and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI). The study page itself still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-26T15:48:26.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The revision identifier in the footer changes from v3.7.1 to v3.7.2; the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-19T15:48:37.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:45:46.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with a generic error page, which blocks access to the study details.
    Difference
    20%
    Check dated 2026-09-21T22:37:36.000Z thumbnail image

Stay in the know with updates to EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EPIK-B2 Study: Alpelisib with Trastuzumab & Pertuzumab Clinical Trial page.